Danaher Co. (NYSE:DHR) Stock Position Raised by Nvwm LLC

Nvwm LLC lifted its position in Danaher Co. (NYSE:DHR) by 1.6% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 5,592 shares of the conglomerate’s stock after buying an additional 89 shares during the quarter. Nvwm LLC’s holdings in Danaher were worth $1,284,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in DHR. AMF Tjanstepension AB bought a new stake in shares of Danaher during the 3rd quarter worth about $5,923,000. Czech National Bank grew its holdings in Danaher by 4.2% during the third quarter. Czech National Bank now owns 130,939 shares of the conglomerate’s stock valued at $36,404,000 after purchasing an additional 5,320 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Danaher by 33.5% in the third quarter. GAMMA Investing LLC now owns 4,480 shares of the conglomerate’s stock valued at $1,246,000 after purchasing an additional 1,125 shares during the period. Diversified Trust Co lifted its stake in shares of Danaher by 29.6% in the third quarter. Diversified Trust Co now owns 5,649 shares of the conglomerate’s stock worth $1,571,000 after buying an additional 1,289 shares during the last quarter. Finally, Miracle Mile Advisors LLC bought a new stake in shares of Danaher during the 3rd quarter worth $310,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 10.90% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of research analyst reports. Jefferies Financial Group cut their target price on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a research report on Wednesday, January 29th. TD Cowen boosted their price objective on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. UBS Group lowered their target price on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a report on Wednesday, October 23rd. Scotiabank initiated coverage on Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective for the company. Finally, Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective on the stock in a research note on Friday, December 13th. Seven equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Price Performance

Shares of Danaher stock opened at $215.05 on Wednesday. Danaher Co. has a 1-year low of $210.04 and a 1-year high of $281.70. The firm’s 50-day moving average price is $234.50 and its two-hundred day moving average price is $252.68. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a market capitalization of $155.33 billion, a price-to-earnings ratio of 40.73, a P/E/G ratio of 2.80 and a beta of 0.83.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the business posted $2.09 earnings per share. On average, equities analysts predict that Danaher Co. will post 7.77 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.50%. The ex-dividend date was Friday, December 27th. Danaher’s dividend payout ratio is currently 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.